vs

Side-by-side financial comparison of Chaince Digital Holdings Inc. (CD) and Cardiff Oncology, Inc. (CRDF). Click either name above to swap in a different company.

Chaince Digital Holdings Inc. is the larger business by last-quarter revenue ($466.6K vs $243.0K, roughly 1.9× Cardiff Oncology, Inc.). Chaince Digital Holdings Inc. runs the higher net margin — -640.5% vs -2969.5%, a 2329.0% gap on every dollar of revenue.

CD vs CRDF — Head-to-Head

Bigger by revenue
CD
CD
1.9× larger
CD
$466.6K
$243.0K
CRDF
Higher net margin
CD
CD
2329.0% more per $
CD
-640.5%
-2969.5%
CRDF

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CD
CD
CRDF
CRDF
Revenue
$466.6K
$243.0K
Net Profit
$-3.0M
$-7.2M
Gross Margin
Operating Margin
-665.1%
-3221.0%
Net Margin
-640.5%
-2969.5%
Revenue YoY
62.0%
Net Profit YoY
38.8%
EPS (diluted)
$-0.05
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CD
CD
CRDF
CRDF
Q4 25
$243.0K
Q3 25
$120.0K
Q2 25
$466.6K
$121.0K
Q1 25
$109.0K
Q4 24
$150.0K
Q3 24
$165.0K
Q2 24
$163.0K
Q1 24
$205.0K
Net Profit
CD
CD
CRDF
CRDF
Q4 25
$-7.2M
Q3 25
$-11.3M
Q2 25
$-3.0M
$-13.9M
Q1 25
$-13.4M
Q4 24
$-11.8M
Q3 24
$-11.9M
Q2 24
$-11.8M
Q1 24
$-10.0M
Operating Margin
CD
CD
CRDF
CRDF
Q4 25
-3221.0%
Q3 25
-9978.3%
Q2 25
-665.1%
-12212.4%
Q1 25
-13194.5%
Q4 24
-8381.3%
Q3 24
-7637.0%
Q2 24
-7696.3%
Q1 24
-5333.2%
Net Margin
CD
CD
CRDF
CRDF
Q4 25
-2969.5%
Q3 25
-9381.7%
Q2 25
-640.5%
-11523.1%
Q1 25
-12324.8%
Q4 24
-7858.0%
Q3 24
-7184.8%
Q2 24
-7225.8%
Q1 24
-4883.4%
EPS (diluted)
CD
CD
CRDF
CRDF
Q4 25
$-0.11
Q3 25
$-0.17
Q2 25
$-0.05
$-0.21
Q1 25
$-0.20
Q4 24
$-0.22
Q3 24
$-0.25
Q2 24
$-0.26
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CD
CD
CRDF
CRDF
Cash + ST InvestmentsLiquidity on hand
$27.2M
$58.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$29.4M
$45.4M
Total Assets
$36.6M
$61.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CD
CD
CRDF
CRDF
Q4 25
$58.3M
Q3 25
$60.6M
Q2 25
$27.2M
$71.0M
Q1 25
$79.9M
Q4 24
$91.7M
Q3 24
$57.7M
Q2 24
$60.3M
Q1 24
$67.2M
Stockholders' Equity
CD
CD
CRDF
CRDF
Q4 25
$45.4M
Q3 25
$48.8M
Q2 25
$29.4M
$58.6M
Q1 25
$70.9M
Q4 24
$82.9M
Q3 24
$49.4M
Q2 24
$52.4M
Q1 24
$60.9M
Total Assets
CD
CD
CRDF
CRDF
Q4 25
$61.9M
Q3 25
$63.8M
Q2 25
$36.6M
$75.7M
Q1 25
$84.8M
Q4 24
$97.2M
Q3 24
$62.9M
Q2 24
$66.1M
Q1 24
$74.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CD
CD
CRDF
CRDF
Operating Cash FlowLast quarter
$-1.3M
$-6.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CD
CD
CRDF
CRDF
Q4 25
$-6.0M
Q3 25
$-10.8M
Q2 25
$-1.3M
$-8.3M
Q1 25
$-12.8M
Q4 24
$-10.3M
Q3 24
$-10.5M
Q2 24
$-9.2M
Q1 24
$-7.7M
Free Cash Flow
CD
CD
CRDF
CRDF
Q4 25
Q3 25
$-10.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$-7.8M
FCF Margin
CD
CD
CRDF
CRDF
Q4 25
Q3 25
-9043.3%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-3814.6%
Capex Intensity
CD
CD
CRDF
CRDF
Q4 25
Q3 25
15.0%
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
39.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons